Aktie A1H89Z STEVIA CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Stevia Corp.

Aktien

A1H89Z

US86031P1066

STEV

Markt geschlossen - OTC Markets
Andere Börsenplätze
 21:10:49 06.05.2024 		% 5 Tage % 1. Jan.
0,003 USD -14,29 % Intraday Chart für Stevia Corp. +7,14 % +50,00 %
2022 Stevia Corp. Ernennung von David L. Cooper zum Mitglied des wissenschaftlichen Beirats CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
BigTime Penny Stocks: Weekly Watchlist (MGRX, PWDY, STEV, BDPT)
Stevia : Announces Appointment of the Former Chief Science Officer for Quest Diagnostics to its Scientific Advisory Panel
Stevia Corp. Announces Appointment of David L. Cooper to Its Scientific Advisory Panel
Stevia : Announces Real Hemp LLC's Collaboration With Internationally Recognized Designer and the Rubber Killer(R) Brand
Stevia : Reports on Budget Hemp's Better Than Expected Sales Numbers Following Launch of Online Store
Stevia : Reports on Initial Sales Trends for Realhemp(TM) Branded Product Lines
Stevia : Launches Its Bulk Hemp Products Online Store at www.BudgetHemp.com for Commercial Buyers
Stevia : Launches Its Online Store at www.RealhempStore.com Featuring Realhemp(TM) Branded Food and Skincare Product Lines
Stevia : Provides Update on 10-K Filing
Stevia : Discusses Partnership Plans While Continuing to Implement a Broad Intellectual Property and Commercial Strategy Related to Cannabis and Industrial Hemp
Stevia : Names Famed Cannabis Researcher and Former Indiana University Professor Paul Mahlberg to Its Advisory Panel
Stevia : Welcomes Biochemist and Former MD Anderson Cancer Researcher Dennis Hill to Its Newly Formed Advisory Panel
Stevia : on Track for Another Record Harvest
Stevia : Files Provisional Patent With the United States Patent and Trademark Office for a Non-Invasive and Simple to Use Delivery System for Cannabinoids
Stevia : Files Two Additional Provisional Patent Applications With the United States Patent and Trademark Office for a Cannabidiol (CBD) and Aspirin Formulation and a Cannabidiol and Naproxen Formulation to Treat Pain and Cardiovascular Disease
Stevia Corp. Files Two Additional Provisional Patent Applications with the United States Patent and Trademark Office for the Treatment of Pain and Cardiovascular Disease
Stevia : Provides Spring Harvest Guidance
Stevia : Announces Investor Update Conference Call
Stevia Corp. cancelled the transaction announced on January 26, 2012
Stevia Corp. Files Second Key Provisional Patent Application with the United States Patent and Trademark Office for a Cannabidiol and Ibuprofen Formulation to Treat Pain
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1H89Z Aktie
  4. Nachrichten Stevia Corp.
  5. Andere Sprachen